MO on NYSE

Altria

Logo: Unknown author Unknown author, Public domain, via Wikimedia Commons6

American tobacco corporation

Altria Group, Inc. is an American corporation and one of the world's largest producers and marketers of tobacco, cigarettes, and medical products in the treatment of illnesses caused by tobacco. It operates worldwide and is headquartered in the city of Richmond, Virginia.3 It was founded by Nabisco, Philip Morris USA and Kraft Foods Group.1 Its chief executive is William F. Gifford, Jr. (since 2020).1 It employed 9,900 people.1 Its revenue was $24 billion in 2024.1 Wikipedia text CC BY-SA 4.0

$73.72 down 0.92 (1.23%)Price as of Oct 21, 2026 at 18:59 UTC

Last updated Oct 21, 2026.

Overview

1985Founded1

Compare with Philip Morris International, RLX Technology Inc. or Ispire Technology Inc., or pick any stock.

  • TickerMO on NYSE1
  • Industryfood industry, tobacco industry1
  • HeadquartersRichmond1
  • Founded inLondon1
  • Websitewww.altria.com
  • Incorporated inVA7
  • Business address6601 West Broad Street, Richmond, Va 232307
  • Filer categoryLarge accelerated filer7
  • Legal formStock Corporation4
  • LEIXSGZFLO9YTNO9VCQV2194
  • StatusActive4
  • LEI statusIssued and current4
  • Registered addressC/O UNITED AGENT GROUP INC., 23434 Suffolk, United States4
  • Registered withState Corporation Commission, 026759994
Altria Building (8156028882)
Photo: Eden, Janine and Jim from New York City, CC BY 2.0, via Wikimedia Commons10

Altria Group, Inc. is an American corporation and one of the world's largest producers and marketers of tobacco, cigarettes, and medical products in the treatment of illnesses caused by tobacco. It operates worldwide and is headquartered in the city of Richmond, Virginia.3

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2025

62.5%Gross margin11
42.5%Operating margin11
29.8%Net margin11
-3.1%Revenue growth, 202511
$9.1BFree cash flow11

What sells

Revenue by product, business segment and region, as the company reports it to the SEC.

Business segments

Smokeable Products brought in 88% of the revenue Altria broke down this way in fiscal 2025.

  1. Smokeable Products$20.5B1188%down 3% from 2024
  2. Oral Tobacco$2.8B1112%up 1% from 2024
  3. Other Operating$5.0M110%up 350% from 2024
Business segments by year
Business segments202320242025
Smokeable Products$21.8B$21.2B$20.5B
Oral Tobacco$2.7B$2.8B$2.8B
Other Operating-$2.0M-$2.0M$5.0M

Where the money goes

Where each dollar of revenue went, fiscal 2025

  • Cost of revenue24¢$5.6B
  • Research and development1¢$195.0M
  • Other costs35¢$8.1B
  • Income tax10¢$2.4B
  • Profit30¢$6.9B

Out of $23.3B in revenue.11

Where each dollar of operating cash went, fiscal 2025

  • Capital spending2¢$216.0M
  • Dividends paid75¢$7.0B
  • Share buybacks11¢$1.0B
  • Kept or used elsewhere12¢$1.1B

Out of $9.3B of cash from operations.11

Financial statements

Revenue1213141511$23.3B in 2025−7% since 2019
0$10.0B$20.0B$30.0B2019: $25.1B$25.1B20192020: $26.2B$26.2B2020+4%2021: $26.0B$26.0B2021−1%2022: $25.1B$25.1B2022−4%2023: $24.5B$24.5B2023−2%2024: $24.0B$24.0B2024−2%2025: $23.3B$23.3B2025−3%
Gross profit1213141511$14.5B in 2025+14% since 2019
0$5.0B$10.0B$15.0B2019: $12.7B$12.7B20192020: $13.0B$13.0B2020+2%2021: $14.0B$14.0B2021+7%2022: $14.2B$14.2B2022+2%2023: $14.3B$14.3B2023+0%2024: $14.4B$14.4B2024+1%2025: $14.5B$14.5B2025+1%
Operating income1213141511$9.9B in 2025−4% since 2019
0$5.0B$10.0B$15.0B2019: $10.3B$10.3B20192020: $10.9B$10.9B2020+5%2021: $11.6B$11.6B2021+6%2022: $11.9B$11.9B2022+3%2023: $11.5B$11.5B2023−3%2024: $11.2B$11.2B2024−3%2025: $9.9B$9.9B2025−12%
Net income1213141511$6.9B in 2025
-$5.0B0$5.0B$10.0B$15.0B2019: -$1.3B-$1.3B20192020: $4.5B$4.5B20202021: $2.5B$2.5B2021−45%2022: $5.8B$5.8B2022+133%2023: $8.1B$8.1B2023+41%2024: $11.3B$11.3B2024+39%2025: $6.9B$6.9B2025−38%

Every line of the income statement as filed: the last 3 fiscal years, latest first.11

Period ending2025-12-312024-12-312023-12-31
Net revenues$23.3B$24.0B$24.5B
Cost of sales$5.6B$6.1B$6.2B
Excise taxes on products$3.1B$3.6B$4.0B
Gross profit$14.5B$14.4B$14.3B
Marketing, administration and research costs$2.5B$2.7B$2.7B
Asset impairment and exit costs, net of cash paid$978.0M$389.0M$0
Impairment of goodwill$1.2B$0$0
Operating income$9.9B$11.2B$11.5B
Interest and other debt expense, net$1.1B$1.0B$989.0M
Net periodic benefit income, excluding service cost-$59.0M-$102.0M-$127.0M
(Income) losses from investments in equity securities-$510.0M-$652.0M-$243.0M
Gain on the sale of IQOS System commercialization rights$0-$2.7B$0
Earnings before income taxes$9.4B$13.7B$10.9B
Provision for income taxes$2.4B$2.4B$2.8B
Net earnings$6.9B$11.3B$8.1B
Basic earnings per share attributable to Altria (in usd per share)$4.12$6.54$4.57
Diluted earnings per share attributable to Altria (in usd per share)$4.12$6.54$4.57

Compare Altria with another company

Corporate structure

Altria sits at the top of its group. 77 entities, 28 countries on record. Switch between the flow chart and the network, and select any entity to see its details.

Major holders of Altria

  • Altria Richmond, Virginia, United States
    • John Middleton Co. Subsidiary
    • Juul Subsidiary · San Francisco
    • Anheuser-Busch InBev Stake · 9.33% · Bruxelles, Belgium
    • Cronos Group Inc Stake · Toronto, Ontario, Canada
    • Chateau Ste. Michelle Subsidiary · Woodinville, United States
    • NJOY, LLC Subsidiary · Delaware, United States
    • Philip Morris USA Inc. Subsidiary · Virginia, United States
    • U.S. Smokeless Tobacco Company LLC Subsidiary · Virginia, United States
    • UST LLC Subsidiary · Virginia, United States
    • Parliament Owned · United States

Built from parent and subsidiary links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); subsidiaries listed in Exhibit 21 of annual reports filed with the SEC; subsidiaries, stakes and holdings from Wikidata (CC0); major holders from Schedules 13D and 13G; stakes of 5% or more it reported on Schedules 13D and 13G (2 companies). Each entity in the chart links to its source.

What it owns

What Altria reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

ItemLatestA year beforeChange
Land and buildings$125.0M11 Dec 31, 2025$124.0M11 Dec 31, 2024+0.8%
Buildings and improvements$1.6B11 Dec 31, 2025$1.6B11 Dec 31, 2024+1.4%
Machinery and equipment$2.7B11 Dec 31, 2025$2.7B11 Dec 31, 2024−0.3%
Construction in progress$320.0M11 Dec 31, 2025$199.0M11 Dec 31, 2024+60.8%
Property and equipment, before depreciation$4.7B11 Dec 31, 2025$4.5B11 Dec 31, 2024+3.0%
Accumulated depreciation$3.0B11 Dec 31, 2025$2.9B11 Dec 31, 2024+1.4%
Property and equipment, net$1.7B11 Dec 31, 2025$1.6B11 Dec 31, 2024+5.8%

Investments

ItemLatestA year beforeChange
Cash and cash equivalents$4.5B11 Dec 31, 2025$3.1B11 Dec 31, 2024+43.1%
Stakes in other companies (equity method)$315.0M15 Dec 31, 2024$17.7B19 Dec 31, 2018−98.2%

Intangibles and goodwill

ItemLatestA year beforeChange
Goodwill$5.8B11 Dec 31, 2025$6.9B11 Dec 31, 2024−16.7%
Intangible assets, net (excluding goodwill)$11.9B11 Dec 31, 2025$13.0B11 Dec 31, 2024−8.5%
Indefinite-lived intangibles (excluding goodwill)$11.1B11 Dec 31, 2025$11.1B11 Dec 31, 20240%
Finite-lived intangibles, gross$1.7B11 Dec 31, 2025$2.6B11 Dec 31, 2024−36.8%
Accumulated amortization$869.0M11 Dec 31, 2025$737.0M11 Dec 31, 2024+17.9%

Inventory

ItemLatestA year beforeChange
Inventory, total$1.1B11 Dec 31, 2025$1.1B11 Dec 31, 2024−0.9%
Work in process$13.0M11 Dec 31, 2025$21.0M11 Dec 31, 2024−38.1%
Finished goods$281.0M11 Dec 31, 2025$278.0M11 Dec 31, 2024+1.1%

Properties, in its own words

ALCS owns one property in Richmond, Virginia that serves as the headquarters facilities for Altria, PM USA, USSTC, Middleton, Helix, NJOY and certain other subsidiaries.

PM USA owns and operates a manufacturing facility located in Richmond, Virginia that PM USA uses in the manufacturing of cigarettes (smokeable products segment). PM USA leases portions of this facility to our other subsidiaries for use in the manufacturing of cigars (smokeable products segment) and oral nicotine pouches (oral tobacco products segment). In addition, PM USA owns a research and technology center in Richmond, Virginia that it leases to ALCS.

The rest of Item 2

The oral tobacco products segment has various manufacturing and processing facilities, the most significant of which are located in Nashville, Tennessee and Hopkinsville, Kentucky.

The plants and properties owned or leased and operated by us are maintained in good condition and are believed to be suitable and adequate for present needs.

Item 2 of the 10-K filed Feb 25, 2026.20

Stakes and holdings (Wikidata)

Things Wikidata records the company as owning, with the share when stated.1

The story

Founded by Kraft Foods Group, Nabisco and Philip Morris USA in 1985, in London.1

Altria emerged from Philip Morris USA. The onset of "rebranding" of Philip Morris Companies to Altria took place in 2003 (Philip Morris would later split, with Philip Morris USA remaining Altria's primary and only consistently held asset). According to Altria, it was created because Philip Morris wished to emphasize that its business portfolio had come to consist of more than Philip Morris USA and Philip Morris International; at the time, it owned an 84% stake in Kraft Foods, although that business has since been spun off. The name "Altria" is claimed to come from the Latin word for "high" and was part of a trend of companies rebranding to names that previously did not exist, Accenture (previously Andersen Consulting) and Verizon being notable examples, though linguist Steven Pinker suggests that in fact the name is an "egregious example" of phonesthesia—with the company attempting to "switch its image from bad people who sell addictive carcinogens to a place or state marked by altruism and other lofty values".

The company's branding consultants, the Wirthlin Group, said: "The name change alternative offers the possibility of masking the negatives associated with the tobacco business", thus enabling the company to improve its image and raise its profile without sacrificing tobacco profits. Philip Morris executives thought a name change would insulate the larger corporation and its other operating companies from the political pressures on tobacco.

The rebranding took place amidst social, legal, and financially troubled circumstances. In 2003 Altria was ranked Fortune number 11, and has steadily declined since. In 2010 Altria Group (MO) ranked at Fortune number 137, whereas its former asset, Philip Morris International, was ranked 94th.

In 2006, a United States court found that Philip Morris "publicly... disputed scientific findings linking smoking and disease knowing their assertions were false." In a 2006 ruling, a federal court found that Altria, along with R. J. Reynolds, Lorillard and Philip Morris were found guilty of misleading the public about the dangers of smoking. Within this ruling, it was noted that "defendants altered the chemical form of nicotine delivered in mainstream cigarette smoke for the purpose of improving nicotine transfer efficiency and increasing the speed with which nicotine is absorbed by smokers." This was done by manipulating smoke pH with ammonia. Adding ammonia increases the smoke pH, in a process called "freebasing" which causes smokers to be "exposed to higher internal nicotine doses and become more addicted to the product."

On March 30, 2007, Altria's 88.1% stake in Kraft Foods was spun off, through a distribution of the remaining stake of shares (88.1%) to Altria shareholders. That same year, Altria began selling all its shares of Philip Morris International to Altria stockholders, a spin-off that was completed on March 28, 2008. Again in 2007 the company began the acquisition of cigar manufacturer John Middleton Co. from Bradford Holdings, which was complete in 2008. After Philip Morris International spun off, the former international subsidiaries halted the purchase of tobacco from America, which was a major factor in the closing of a newly renovated plant in North Carolina, an approximately 50% reduction in manufacturing, large-scale layoffs, and induced early retirements.

In 2008, Altria officially moved its headquarters from New York City to Richmond, Virginia, after Philip Morris sold its downtown offices in New York City a decade earlier. With a few exceptions, all manufacturing, commercial, and executive employees had long been based in and around Richmond. The company is now headquartered in an unincorporated area within Henrico County, less than five miles (8.0 km) west of the city limits of Richmond and less than 10 miles (16 km) from its downtown Richmond campus.

Aside from the Philip Morris/Altria headquarters, some of their other buildings included the Altria Center for Research and Technology in downtown Richmond, their manufacturing center in South Richmond, and the adjacent operations center which began shutting down in 2007–2008, as a result of the loss of demand from Philip Morris International member companies. The layoffs beginning in 2007 affected thousands of Altria, Altria Client Services, Philip Morris USA, and contracted employees in Richmond and North Carolina.

In 2009, Altria finalized its purchase of UST Inc., whose products included smokeless tobacco (made by U.S. Smokeless Tobacco Company) and wine (made by Chateau Ste. Michelle). This ended a short era of competition between the new Marlboro smokeless tobacco products such as snus, and those produced by UST Inc.

Read the full text

On December 8, 2018, Altria announced its intent to acquire a 45% stake in Cronos Group for $1.8 billion.

On December 20, 2018, Altria finalized the acquisition of a 35% stake in JUUL Labs, an e-cigarette company based out of San Francisco, California, for $12.8 billion. On November 3, 2019, it was reported that Altria was taking a $4.5 billion writedown on its stake in Juul, 35% of its original value. On July 28, 2022, it was reported that Altria's investment in Juul is now worth only 5% of the original amount of $12.8 billion. Despite the losses, Altria has announced that it will continue to support Juul and avoid investing in competing products.

Altria is taking a stake in the global business of Swiss tobacco company Burger Söhne (Helix Innovations with the On! brand) for $372 million in June 2019.

Altria and Japan Tobacco announced a joint venture called Horizon Innovations LLC on October 27, 2022. Horizon, owned 75 percent by Altria and 25 percent by Japan Tobacco, intends to sell Ploom heated tobacco sticks in the United States. FDA approval was expected to take until 2025, with customers able to buy Ploom by 2027.

Altria completed the acquisition of NJOY Holdings, Inc. on June 1, 2023.

From Wikipedia’s article on Altria, shared under CC BY-SA 4.0.8

Leadership

Who has led Altria, and when. Pick a name to see everywhere that person has worked.

Board members and other officers (59)

Products and brands

  • tobacco
  • tobacco product

Listed on Wikidata.1

Subsidiaries and ownership

Subsidiaries

Also owns

Subsidiaries (Exhibit 21)

  • NJOY, LLC Delaware9
  • Philip Morris USA Inc. Virginia9
  • U.S. Smokeless Tobacco Company LLC Virginia9
  • UST LLC Virginia9

From Wikidata.1 The subsidiaries the company lists in Exhibit 21 of its annual report, as filed.

Former names

  • ALTRIA GROUP INCJan 29, 2003 to Feb 7, 20067
  • PHILIP MORRIS COMPANIES INCApr 13, 1994 to Jan 2, 20037

Timeline

  1. Oct 9, 20268-K Entered a material agreement96
  2. Aug 28, 20268-K Executive or director change; Regulation FD disclosure97
  3. Jul 30, 20268-K Results of operations98
  4. May 18, 20268-K Executive or director change; Shareholder vote99
  5. May 15, 2026New chief executive Salvatore Mancuso becomes CEO21
  6. Apr 30, 20268-K Results of operations100
  7. Jan 29, 20268-K Results of operations; Executive or director change101
  8. Jan 29, 20268-K Other events102
  9. Dec 11, 20258-K Executive or director change; Regulation FD disclosure103
  10. Oct 30, 20258-K Results of operations; Other events104
  11. Oct 9, 20258-K Executive or director change; Regulation FD disclosure105
  12. Aug 6, 20258-K Other events106
  13. Jul 30, 20258-K Results of operations107
  14. Apr 16, 2020New chief executive William F. Gifford, Jr. becomes CEO1
  15. May 21, 2018New chief executive Howard A. Willard becomes CEO23
  16. May 3, 2017New chief executive Kevin C. Crosthwaite Jr. becomes CEO24
  17. Nov 21, 2013New chief executive Clifford B. Fleet becomes CEO25
  18. May 18, 2012New chief executive Martin J. Barrington becomes CEO27
  19. Apr 17, 2012New chief executive Brian W. Quigley becomes CEO26
  20. Sep 10, 2009New chief executive Peter P. Paoli becomes CEO28
  21. Jul 6, 2006New chief executive Irene Rosenfeld becomes CEO32
  22. Jan 27, 2006New chief executive Michael E. Szymanczyk becomes CEO31
  23. Jan 27, 2006New chief executive Louis C. Camilleri becomes CEO30
  24. Jan 27, 2006New chief executive André Calantzopoulos becomes CEO29
  25. 1985Founded Founded in London1

Calendar

Coming up

  1. Oct 29, 2026 · Before the openReports results for the quarter ending Sep/2026 A year earlier it reported $1.45 a share, on Oct 30, 2025.108

When it reported results

  1. Jul 30, 2026Reported quarterly or annual results98
  2. Apr 30, 2026Reported quarterly or annual results100
  3. Jan 29, 2026Reported quarterly or annual results101
  4. Oct 30, 2025Reported quarterly or annual results104
  5. Jul 30, 2025Reported quarterly or annual results107
  6. Apr 29, 2025Reported quarterly or annual results109
  7. Jan 30, 2025Reported quarterly or annual results110
  8. Oct 31, 2024Reported quarterly or annual results111

Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar

Filings

335 filings to the SEC since October 2021: 10 annual reports, 15 quarterly reports, 55 major events, 191 insider forms, 10 large holders, 54 other. The latest 20:

  1. Oct 9, 20268-K EDGAR
  2. Sep 11, 20264 EDGAR
  3. Sep 2, 20263 EDGAR
  4. Aug 28, 20268-K EDGAR
  5. Jul 30, 202610-Q EDGAR
  6. Jul 30, 20268-K EDGAR
  7. Jun 5, 202611-K 2025 HOURLY DPS PLAN EDGAR
  8. Jun 5, 202611-K 2025 SALARIED DPS PLAN EDGAR
  9. May 28, 20264 EDGAR
  10. May 28, 20264 EDGAR
  11. May 28, 2026SD EDGAR
  12. May 27, 202610-K/A EDGAR
  13. May 26, 2026144/A EDGAR
  14. May 26, 2026144 EDGAR
  15. May 26, 2026144 EDGAR
  16. May 18, 20268-K EDGAR
  17. May 18, 20264 EDGAR
  18. May 18, 20264 EDGAR
  19. May 18, 20264 EDGAR
  20. May 18, 20264 EDGAR

The 335 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

7 open-market trades by officers, directors and large owners since October 2021: 3 buys and 4 sales. Grants, option exercises and gifts are left out.

DateWhoTradeSharesPriceValueFiling
Sep 9, 2026McQUADE KATHRYN B.DirectorBuy1,500$67.62$101.4KForm 4
May 26, 2026KELLY ENNIS DEBRA JDirectorSale5,790$72.25$418.3KForm 4
May 26, 2026Strahlman Ellen RDirectorSale2,000$72.56$145.1KForm 4
Mar 5, 2026Whitaker Charles N.SVP, Chief HR Off. & CCOSale27,908$67.57$1.9MForm 4
May 2, 2024Whitaker Charles N.SVP, Chief HR Off. & CCOSale22,487$43.95$988.3KForm 4
Nov 6, 2023Davis Robert MatthewsDirectorBuy1,200$40.50$48.6KForm 4
Nov 6, 2023Clarke Ian L.T.DirectorBuy1,100$40.57$44.6KForm 4

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

Stakes it holds

Altria has told the SEC it owns more than 5% of 2 companies, latest first (Schedules 13D and 13G).

Held by these funds

The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026, the top 25 of 100. Change is in shares since the quarter before.

FundSharesValueShare of the fundChange
BlackRock, Inc.126,073,166$9.1B0.1%+1,325,175
Vanguard Capital Management LLC109,032,952$7.8B0.2%+196,910
State Street Corp70,192,620$5.1B0.2%−1,599,699
Charles Schwab Investment Management Inc59,122,097$4.3B0.6%+4,841,988
Capital Research Global Investors58,653,624$4.2B0.6%+32,973,712
Geode Capital Management, LLC47,721,870$3.4B0.2%+699,212
Vanguard Portfolio Management LLC33,719,478$2.4B0.1%−1,488,710
GQG Partners LLC25,111,622$1.8B3.4%+1,274,783
Morgan Stanley22,702,935$1.6B0.1%−1,752,794
Ameriprise Financial Inc22,047,402$1.6B0.3%+544,333
Capital World Investors18,480,673$1.3B0.2%+64,574
PeakShares LLC17,780$1.3B1.0%+1,338
Northern Trust Corp15,604,968$1.1B0.1%−434,426
Bank Of America Corp /de/15,351,862$1.1B0.1%+252,041
Goldman Sachs Group Inc13,862,242$997.4M0.1%+749,548
Jpmorgan Chase & Co12,207,565$904.0M0.1%−848,701
Bank of New York Mellon Corp12,549,406$902.9M0.1%−379,736
Invesco Ltd.11,724,425$843.6M0.1%−3,724
Vanguard Fiduciary Trust Co9,376,660$674.7M0.1%−66,923
UBS Group AG8,870,398$638.2M0.1%+1,311,387
Legal & General Group Plc8,778,401$631.6M0.1%−1,043,648
Assenagon Asset Management S.A.7,213,122$519.0M0.3%+7,117,991
Arrowstreet Capital, Limited Partnership7,082,195$509.6M0.2%−2,120,045
First Trust Advisors LP6,379,718$459.0M0.3%−333,585
Raymond James Financial Inc6,336,137$455.9M0.1%+750,018

13F reports cover disclosed long positions in U.S. stocks only.

Members of Congress who traded it

47 trades disclosed by members of Congress, the latest 25. “Vs S&P since” is the stock’s change since the trade minus the S&P 500’s.

DateMemberTradeAmountVs S&P sinceFiling
Mar 27, 2026Alan ArmstrongRepublican, SenateBuy$1,001 - $15,000−10.6%Report
Mar 19, 2025Sheri BiggsRepublican, HouseSale$1,001 - $15,000+8.7%Report
Sep 10, 2024Pete SessionsRepublican, HouseSale$1,001 - $15,000+4.1%Report
Jan 16, 2024Virginia FoxxRepublican, HouseSale$1,001 - $15,000−17.7%Report
Jan 11, 2024Virginia FoxxRepublican, HouseBuy$1,001 - $15,000+15.5%Report
Jan 10, 2024Virginia FoxxRepublican, HouseSale$15,001 - $50,000−17.9%Report
Nov 22, 2023J. French HillRepublican, HouseSale$50,001 - $100,000−9.7%Report
Oct 11, 2023Virginia FoxxRepublican, HouseBuy$1,001 - $15,000−3.4%Report
Jul 14, 2023Daniel S. GoldmanDemocratic, HouseSale$1,001 - $15,000+9.5%Report
Jul 12, 2023Daniel S. GoldmanDemocratic, HouseSale$1,001 - $15,000+11.4%Report
Jul 11, 2023Virginia FoxxRepublican, HouseBuy$1,001 - $15,000−12.6%Report
May 1, 2023Virginia FoxxRepublican, HouseBuy$1,001 - $15,000−31.2%Report
Apr 10, 2023Daniel S. GoldmanDemocratic, HousePartial sale$1,001 - $15,000+22.5%Report
Feb 3, 2023Daniel S. GoldmanDemocratic, HouseBuy$1,001 - $15,000−29.8%Report
Jan 31, 2023Daniel S. GoldmanDemocratic, HouseBuy$15,001 - $50,000−25.9%Report
Jan 17, 2023Virginia FoxxRepublican, HouseBuy$1,001 - $15,000−30.5%Report
Dec 6, 2022Virginia FoxxRepublican, HouseBuy$50,001 - $100,000−36.2%Report
Aug 3, 2022Kathy Manning, HouseSale$1,001 - $15,000+19.3%Report
Jul 20, 2022Kathy Manning, HouseBuy$1,001 - $15,000−21.0%Report
Jun 29, 2022Virginia FoxxRepublican, HouseSale$100,001 - $250,000+26.1%Report
May 2, 2022Virginia FoxxRepublican, HouseBuy$1,001 - $15,000−52.9%Report
Mar 16, 2022John H. RutherfordRepublican, HouseSale$1,001 - $15,000+33.2%Report
Jan 11, 2022Virginia FoxxRepublican, HouseBuy$1,001 - $15,000−15.1%Report
Oct 13, 2021Virginia FoxxRepublican, HouseBuy$1,001 - $15,000−23.3%Report
Aug 19, 2021David RouzerRepublican, HouseSale$1,001 - $15,000+22.4%Report

Members report amounts as ranges, not exact figures. Returns are price-only (no dividends).

SEC filer profile

How Altria is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARALTRIA GROUP, INC.2
  • CIK0000764180
  • Employer ID (EIN)13-326024520
  • Filer statusLarge accelerated filer not an emerging growth company; not a smaller reporting company; not a shell company20
  • Incorporated inVirginia20
  • Fiscal year endsDecember 312
  • Industry code (SIC)2111 Cigarettes2
  • SEC reviewing officeOffice of Manufacturing, Division of Corporation Finance2
  • Business address6601 West Broad Street, Richmond, VA 232302
  • Phone(804) 274-22002
  • Shares outstanding1,669,743,926 as of Jul 22, 202617
  • Public float$98.0B as of Jun 30, 202520
  • AuditorPricewaterhouseCoopers LLP, Richmond, Virginia PCAOB ID 238; it also attests to the company’s internal control over financial reporting20
  • On EDGAR sinceFeb 28, 19942
  • Filings2,528 in all: 4 (1,510), 8-K (374), 10-Q (98), 11-K (93), 3 (55), SC 13G/A (45), 424B2 (41), DEF 14A (33)2
    All 45 form types

    DEFA14A (31), 10-K (28), S-8 (22), FWP (18), UPLOAD (18), 10-K/A (13), CORRESP (13), 424B3 (12), 8-K/A (12), ARS (10), NO ACT (10), 424B5 (8), SC 13D/A (8), SC 13G (8), SD (8), PX14A6G (7), S-8 POS (7), 144 (6), S-3ASR (6), 10-K405 (5), 5 (4), 3/A (3), 10-Q/A (2), 144/A (2), 25-NSE (2), 4/A (2), S-3 (2), S-3/A (2), SC 13D (2), 15-12B (1), 5/A (1), 8-A12B (1), CERT (1), PRE 14A (1), SCHEDULE 13D/A (1), SCHEDULE 13G (1), SCHEDULE 13G/A (1)

  • Latest filingsAnnual report (10-K) Feb 25, 2026
    Quarterly report (10-Q) Jul 30, 2026
    Proxy statement (DEF 14A) Apr 2, 2026
    Latest 8-K (8-K) Oct 9, 2026

Securities registered for trading

ClassSymbolExchange
Common Stock, $0.33 1/3 par valueMONew York Stock Exchange
2.200% Notes due 2027MO27New York Stock Exchange
3.125% Notes due 2031MO31New York Stock Exchange

From the cover page of the 10-K filed Feb 25, 2026 (Section 12(b) of the Exchange Act).20

Risk factors and legal proceedings

The risks Altria names in Item 1A of its 10-K filed Feb 25, 2026: 25 risks under these headings, as written.20

  • Risks Relating to Our Business
  • Business Operations Risks
  • We may be unsuccessful in anticipating and responding to changes in adult nicotine consumer purchase behavior, including as a result of difficult economic conditions, and preferences, each of which could have a material adverse effect on our business, results of operations, cash flows or financial position.
  • We face significant competition, including from the growth of innovative nicotine products, and our failure to compete effectively could have a material adverse effect on our business, results of operations, cash flows or financial position and our ability to achieve our Vision.
  • We may be unsuccessful in commercializing innovative products, including nicotine products with reduced health risks relative to certain other nicotine products and that appeal to adult nicotine consumers, which may have a material adverse effect on our business, results of operations, cash flows or financial position and our ability to achieve our Vision.
  • Our inability to successfully counter the effects of illicit trade in nicotine products, including e-vapor products, could have a material adverse effect on our business, results of operations, cash flows or financial position and our ability to achieve our Vision.
  • Failure to complete or manage strategic transactions, including acquisitions, dispositions, joint ventures and commercial relationships with and investments in third parties, or realize the anticipated benefits of such transactions, could have a material adverse effect on our business, financial position and our ability to achieve our Vision.
  • Significant changes in price, availability or quality of tobacco, other raw materials or component parts could have a material adverse effect on our profitability and business.
  • Our operating companies rely on a few significant facilities and a small number of key suppliers, distributors and distribution chain service providers, and an extended disruption at a facility or in service by a supplier, distributor or distribution chain service provider could have a material adverse effect on our business, results of operations, cash flows or financial position.
  • We may be required to write down goodwill and other intangible assets, including trademarks and other intellectual property, due to impairment, which could have a material adverse effect on our results of operations or financial position.
  • Our Optimize & Accelerate initiative may expose us to increased risks relating to business continuity and our internal control over financial reporting and audit procedures, among others, which could have a material adverse impact on our business, cash flows, financial position or results of operations.
  • Our operating companies could decide, or be required to, recall products, which could have a material adverse effect on our business, reputation, results of operations, cash flows or financial position.
The other 15 risks
  • We face various risks related to health epidemics and pandemics, and such events, and the measures that international, federal, state and local governments, agencies, law enforcement and health authorities implement to address them, could have a material adverse effect on our business, results of operations, cash flows or financial position.
  • We may be unable to attract and retain a highly skilled workforce due to the decreasing social acceptance of tobacco usage, tobacco control actions and other factors, which could have a material adverse effect on our business and our ability to achieve our Vision.
  • Litigation, Legislative and Regulatory Risks
  • Unfavorable outcomes with respect to litigation proceedings or any governmental investigations could materially adversely affect our results of operations, cash flows or financial position and our ability to achieve our Vision.
  • Significant federal, state and local governmental actions, including FDA regulatory actions and inaction, and various private sector actions may continue to have a material adverse impact on our operating companies’ sales volumes and our business.
  • Nicotine products are subject to substantial taxation, and any increases in nicotine product-related taxes could have a material adverse impact on sales of our operating companies’ products.
  • International business operations subject us to various U.S. and foreign laws and regulations, and violations of such laws or regulations could result in reputational harm, legal challenges and significant penalties and other costs.
  • A challenge to our tax positions, an increase in the income tax rate or other changes to federal or state tax laws could materially adversely affect our earnings or cash flows.
  • Legal and regulatory requirements related to climate change and other environmental sustainability matters could have a material adverse impact on our business and results of operations.
  • Capital Markets and Financing Risks
  • Disruption and uncertainty in the credit and capital markets could materially adversely affect our business.
  • A downgrade or potential downgrade of our credit ratings could adversely impact our borrowing costs and access to credit and capital markets, which could materially adversely affect our financial condition.
  • Our performance relating to corporate responsibility matters and investor and stakeholder responses thereto may impact our reputation, ability to attract investors and the market value of our stock.
  • Information Technology and Data Privacy Risks
  • The failure of our, or our service providers’, key suppliers’ or trade customers’, information systems to function as intended, or cyber-attacks or security breaches, could have a material adverse effect on our business, reputation, results of operations, cash flows or financial position.
  • Our failure, or the failure of our service providers, key suppliers or trade customers, to comply with personal data protection, privacy, artificial intelligence and information security laws could materially adversely affect our business.
  • Risks Relating to Our Investments in Equity Securities
  • The expected benefits of our investment in ABI may not materialize in the expected manner or timeframe or at all, which could have a material adverse impact on our financial position or earnings.
  • Our investment in Cronos subjects us to certain risks associated with Cronos’s business, including legal, regulatory and reputational risks.

Legal proceedings

The information required by this Item is included in Note 18 and Exhibits 99.1 and 99.2 to this Form 10-K. Altria’s consolidated financial statements and accompanying notes for the year ended December 31, 2025 were filed on Form 8-K on January 29, 2026 (such consolidated financial statements and accompanying notes are also included in Item 8). The following summarizes certain developments in Altria’s litigation since the filing of the Form 8-K.

Recent Developments

▪Health Care Cost Recovery Litigation

Continuing NPM Adjustment Disputes with States That Have Not Settled. In February 2026, an arbitration panel found that Missouri was not diligent in the enforcement of its escrow statutes in 2005.

The opening of Item 3, Legal Proceedings.20

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
    Yahoo FinanceMO quote
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32
  33. 33
  34. 34
  35. 35
  36. 36
  37. 37
  38. 38
  39. 39
  40. 40
  41. 41
  42. 42
  43. 43
  44. 44
  45. 45
  46. 46
  47. 47
  48. 48
  49. 49
  50. 50
  51. 51
  52. 52
  53. 53
  54. 54
  55. 55
  56. 56
  57. 57
  58. 58
  59. 59
  60. 60
  61. 61
  62. 62
  63. 63
  64. 64
  65. 65
  66. 66
  67. 67
  68. 68
  69. 69
  70. 70
    Wikidata and SEC EDGARIan L.T. Clarke, Board member
  71. 71
  72. 72
  73. 73
  74. 74
  75. 75
    Wikidata and SEC EDGAREllen R. Strahlman, Board member
  76. 76
    Wikidata and SEC EDGARVirginia E. Shanks, Board member
  77. 77
  78. 78
  79. 79
    Wikidata and SEC EDGARKathryn B. McQuade, Board member
  80. 80
  81. 81
  82. 82
  83. 83
  84. 84
  85. 85
  86. 86
  87. 87
  88. 88
  89. 89
  90. 90
  91. 91
    Wikidata and SEC EDGARGeorge Muñoz, Board member
  92. 92
  93. 93
  94. 94
  95. 95
  96. 96
  97. 97
  98. 98
  99. 99
  100. 100
  101. 101
  102. 102
    SEC EDGAROther events
  103. 103
  104. 104
  105. 105
  106. 106
    SEC EDGAROther events
  107. 107
  108. 108
  109. 109
  110. 110
  111. 111
  112. 112
  113. 113
  114. 114
  115. 115
  116. 116
  117. 117